# Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

> **NCT01196897** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 69 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** WATCHMAN LAA Closure Technology (Gen 4.0)

## Key facts

- **NCT ID:** NCT01196897
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-09
- **Final completion:** 2013-11
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2015-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01196897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01196897, "Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01196897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*